An endangered tribe has developed a severe skeletal deformity. A university research has identified a mineral supplement as a possible remedy, though clinical trials are yet to be conducted. Should the District Magistrate (DM) use this research on the tribe? Discuss from the perspective of medical and administrative ethics.
150 words, 10 marks. Define the concept precisely, then apply it to the situation — Ethics rewards the application, not the definition.
Common trap: Answer the question asked — should he, yes or no — then justify. A balanced discussion that never says no reads as evasion on a question with a clear ethical answer.
Model answer
162 words · 150-word limitNo — not as proposed. Administering an untested supplement to an endangered, poorly informed population is precisely what research ethics exists to prevent.
Medical ethics forbids it. Non-maleficence weighs against an untrialled intervention on an already severe condition. Autonomy is compromised because consent obtained under the DM's authority is inherently pressured and, given low literacy, doubtfully informed. Justice requires that vulnerable groups not carry research risk for benefits accruing elsewhere — the Nuremberg Code and Declaration of Helsinki exist because historically they did.
Administrative ethics adds a second objection. The DM is not the competent authority to authorise a trial; that rests with an Institutional Ethics Committee and the drug regulator. Acting outside jurisdiction, however compassionate, is an abuse of office and leaves the community without redress.
He should refer the research for ethical clearance and a regulated trial under ICMR guidelines, while acting at once on nutrition, safe water and screening camps. Compassion is the right motive and the wrong authorisation.
Answer plan — how to structure itShowHide
Open with: An untested intervention on an endangered, poorly informed population is precisely the situation research ethics was written to prevent — but inaction where a remedy may exist is also a moral choice.
Medical ethics says no, as proposed
- Non-maleficence — an untrialled supplement may worsen a condition already severe
- Autonomy and informed consent — consent is doubtful where literacy is low and the DM's authority is itself coercive
- Justice — vulnerable populations must not bear research risk for benefits that accrue elsewhere; the Nuremberg Code and Helsinki Declaration exist because they historically did
- Beneficence cannot be asserted without evidence; a possible remedy is not a remedy
Administrative ethics
- The DM is not a competent authority to authorise a medical trial — that lies with an Institutional Ethics Committee and the drug regulator
- Acting outside jurisdiction, however well-intentioned, is an abuse of office
- Accountability: if harm follows, the community has no redress against a decision taken informally
What the DM should do instead
- Refer the research for formal ethical clearance and regulated clinical trial under ICMR National Ethical Guidelines
- Meanwhile act on what is already established — nutrition, safe water, screening, specialist camps, and investigation of environmental causes such as fluorosis
- Ensure community representation and translated communication throughout
Draw: A decision gate diagram — proposed action stopped at three gates: competent authority, ethics clearance, informed consent.
Close with: Compassion is the right motive and the wrong authorisation; the DM's duty is to route the remedy through the process that protects the tribe, not to bypass it on their behalf.
Read more — sources
- termBeauchamp and Childress — autonomy, beneficence, non-maleficence, justice
- thinkerKant — persons as ends in themselves; the categorical bar on using people as experimental means
- EdiShorts appMains GS-4 — Applied Ethics: Medical & Research
Related questions from earlier years
More from GS Paper 4 (Ethics) 2026
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.